Holen Sie sich die Stockscreener-App
16.18
2.94%
-0.48
Schlusskurs vom Vortag:
$16.66
Offen:
$16.87
24-Stunden-Volumen:
16,997
Relative Volume:
0.43
Marktkapitalisierung:
$311.22M
Einnahmen:
$54,000
Nettoeinkommen (Verlust:
$-210.26M
KGV:
-20.48
EPS:
-0.79
Netto-Cashflow:
$-159.01M
1W Leistung:
-6.15%
1M Leistung:
-8.90%
6M Leistung:
+75.30%
1J Leistung:
-27.81%
1-Tages-Spanne:
$15.94
$17.31
1-Wochen-Bereich:
$15.94
$17.59
52-Wochen-Spanne:
$7.65
$30.00
Lyell Immunopharma Inc Stock (LYEL) Company Profile
Firmenname
Lyell Immunopharma Inc
Sektor
Branche
Telefon
650 695-0677
Adresse
201 HASKINS WAY, SOUTH SAN FRANCISCO
Vergleichen Sie LYEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LYEL
Lyell Immunopharma Inc
|
16.20 | 320.06M | 54,000 | -210.26M | -159.01M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.18 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.37 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.51 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.32 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-30 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-06-27 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-08-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-11-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-11 | Herabstufung | Goldman | Buy → Neutral |
| 2022-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-07-12 | Eingeleitet | BofA Securities | Buy |
| 2021-07-12 | Eingeleitet | Goldman | Buy |
| 2021-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-12 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Lyell Immunopharma Inc Aktie (LYEL) Neueste Nachrichten
Lyell’s dual-targeting CAR T-cell therapy shows promise in lymphoma - Investing.com
Strategies to average down on Lyell Immunopharma Inc.Buy Signal & Risk Controlled Stock Alerts - newser.com
Is Lyell Immunopharma Inc. stock overvalued by current metricsTrade Analysis Report & Expert Verified Stock Movement Alerts - newser.com
How Lyell Immunopharma Inc. stock performs in weak economyWeekly Profit Recap & Daily Volume Surge Signals - newser.com
Lyell Immunopharma Appoints New Financial Leadership Team - TipRanks
Lyell (Nasdaq: LYEL) to present Phase 1/2 ronde-cel LBCL at ASH; FDA RMAT & Fast Track - Stock Titan
Is Lyell Immunopharma Inc. stock attractive for retirement portfoliosQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - newser.com
Volatility clustering patterns for Lyell Immunopharma Inc.July 2025 Drop Watch & Stepwise Trade Execution Plans - newser.com
Real time social sentiment graph for Lyell Immunopharma Inc.2025 Momentum Check & Stock Portfolio Risk Management - newser.com
Will Lyell Immunopharma Inc. benefit from macro trendsWeekly Risk Report & Trade Opportunity Analysis Reports - newser.com
Tick level data insight on Lyell Immunopharma Inc. volatilityTrade Analysis Summary & Safe Capital Allocation Plans - newser.com
Is this a good reentry point in Lyell Immunopharma Inc.Recession Risk & Low Risk Entry Point Tips - newser.com
How to manage a losing position in Lyell Immunopharma Inc.July 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - newser.com
How to track smart money flows in Lyell Immunopharma Inc.July 2025 Update & Trade Opportunity Analysis - newser.com
Technical signs of recovery in Lyell Immunopharma Inc.2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
How institutional ownership impacts Lyell Immunopharma Inc. stock2025 Volatility Report & Growth-Oriented Investment Plans - newser.com
Published on: 2025-10-31 03:26:35 - newser.com
Is it too late to sell Lyell Immunopharma Inc.Portfolio Gains Report & Weekly Stock Performance Updates - newser.com
Is Lyell Immunopharma Inc. still worth holding after the dipWeekly Profit Recap & Precise Swing Trade Entry Alerts - newser.com
Published on: 2025-10-30 06:17:45 - newser.com
Lyell Immunopharma (LYEL) to Release Quarterly Earnings on Thursday - MarketBeat
Published on: 2025-10-30 02:39:25 - newser.com
What hedge fund activity signals for Lyell Immunopharma Inc. stockWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-10-28 05:46:43 - newser.com
Lyell Immunopharma Inc Stock Analysis and ForecastTrading Psychology Tips & Achieve Triple Digit Returns - earlytimes.in
Published on: 2025-10-27 19:50:03 - newser.com
Finanzdaten der Lyell Immunopharma Inc-Aktie (LYEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):